Durvalumab is an anticancer regimen that is used for the treatment of patients with non-small cell lung cancer. It is an effective medication that treats the condition by interfering with the immune system’s function. This medicine is marketed under different brand names including imfinzi tablet. It is available as an intravenous infusion (injection to be given into a vein).
Lorlatinib is a lung cancer medicine that is used specifically for the treatment of patients suffering from non-small cell lung cancer (NSCLC). It is available as lorbrena tablets with a fixed strength of 100mg. This medication works by inhibiting the proteins that help in cell multiplication.